323 related articles for article (PubMed ID: 15270406)
1. Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.
Bordallo MA; Guimarães MM; Pessoa CH; Carriço MK; Dimetz T; Gazolla HM; Dobbin J; Castilho IA
J Pediatr Endocrinol Metab; 2004 Jun; 17(6):879-87. PubMed ID: 15270406
[TBL] [Abstract][Full Text] [Related]
2. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
[TBL] [Abstract][Full Text] [Related]
3. Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis.
Tsatsoulis A; Shalet SM; Morris ID; de Kretser DM
Horm Res; 1990; 34(5-6):254-9. PubMed ID: 2129227
[TBL] [Abstract][Full Text] [Related]
4. [Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
Soriano Guillén L; Muñoz Calvo MT; Pozo Román J; Contra Gómez T; Buño Soto M; Argente Oliver J
An Esp Pediatr; 2000 Oct; 53(4):318-23. PubMed ID: 11083980
[TBL] [Abstract][Full Text] [Related]
5. Gonadal status in male survivors following childhood brain tumors.
Schmiegelow M; Lassen S; Poulsen HS; Schmiegelow K; Hertz H; Andersson AM; Skakkebaek NE; Müller J
J Clin Endocrinol Metab; 2001 Jun; 86(6):2446-52. PubMed ID: 11397837
[TBL] [Abstract][Full Text] [Related]
6. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence.
Brämswig JH; Heimes U; Heiermann E; Schlegel W; Nieschlag E; Schellong G
Cancer; 1990 Mar; 65(6):1298-302. PubMed ID: 2106384
[TBL] [Abstract][Full Text] [Related]
7. Low serum inhibin B levels as a marker of testicular damage after treatment for a childhood malignancy.
Cicognani A; Cacciari E; Pasini A; Burnelli R; De Iasio R; Pirazzoli P; Paolucci G
Eur J Pediatr; 2000; 159(1-2):103-7. PubMed ID: 10653341
[TBL] [Abstract][Full Text] [Related]
8. Testicular function in a birth cohort of young men.
Hart RJ; Doherty DA; McLachlan RI; Walls ML; Keelan JA; Dickinson JE; Skakkebaek NE; Norman RJ; Handelsman DJ
Hum Reprod; 2015 Dec; 30(12):2713-24. PubMed ID: 26409015
[TBL] [Abstract][Full Text] [Related]
9. Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer?
Crofton PM; Thomson AB; Evans AE; Groome NP; Bath LE; Kelnar CJ; Wallace WH
Clin Endocrinol (Oxf); 2003 Mar; 58(3):296-301. PubMed ID: 12608934
[TBL] [Abstract][Full Text] [Related]
10. Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
Dhabhar BN; Malhotra H; Joseph R; Garde S; Bhasin S; Sheth A; Advani SH
Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):306-10. PubMed ID: 8328644
[TBL] [Abstract][Full Text] [Related]
11. Testicular Sertoli cell function in male systemic lupus erythematosus.
Suehiro RM; Borba EF; Bonfa E; Okay TS; Cocuzza M; Soares PM; Silva CA
Rheumatology (Oxford); 2008 Nov; 47(11):1692-7. PubMed ID: 18786967
[TBL] [Abstract][Full Text] [Related]
12. The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
Gerres L; Brämswig JH; Schlegel W; Jürgens H; Schellong G
Cancer; 1998 Nov; 83(10):2217-22. PubMed ID: 9827728
[TBL] [Abstract][Full Text] [Related]
13. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
[TBL] [Abstract][Full Text] [Related]
14. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
Clark ST; Radford JA; Crowther D; Swindell R; Shalet SM
J Clin Oncol; 1995 Jan; 13(1):134-9. PubMed ID: 7799013
[TBL] [Abstract][Full Text] [Related]
15. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
Behringer K; Mueller H; Goergen H; Thielen I; Eibl AD; Stumpf V; Wessels C; Wiehlpütz M; Rosenbrock J; Halbsguth T; Reiners KS; Schober T; Renno JH; von Wolff M; van der Ven K; Kuehr M; Fuchs M; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Jan; 31(2):231-9. PubMed ID: 23150709
[TBL] [Abstract][Full Text] [Related]
16. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
van den Berg H; Furstner F; van den Bos C; Behrendt H
Pediatr Blood Cancer; 2004 Mar; 42(3):210-5. PubMed ID: 14752856
[TBL] [Abstract][Full Text] [Related]
17. Reproductive hormones of ICSI-conceived young adult men: the first results.
Belva F; Roelants M; De Schepper J; Van Steirteghem A; Tournaye H; Bonduelle M
Hum Reprod; 2017 Feb; 32(2):439-446. PubMed ID: 28007789
[TBL] [Abstract][Full Text] [Related]
18. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease.
Heikens J; Behrendt H; Adriaanse R; Berghout A
Cancer; 1996 Nov; 78(9):2020-4. PubMed ID: 8909325
[TBL] [Abstract][Full Text] [Related]
19. Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease.
Kreuser ED; Xiros N; Hetzel WD; Heimpel H
J Cancer Res Clin Oncol; 1987; 113(3):260-6. PubMed ID: 3108263
[TBL] [Abstract][Full Text] [Related]
20. Gonadal function and fertility in male survivors treated for Hodgkin's disease in Iran.
Rafsanjani KA; Faranoush M; Hedayatiasl AA; Vossough P
Saudi Med J; 2007 Nov; 28(11):1690-3. PubMed ID: 17965791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
